|
|
Founded in 1984, CryoLife is a biomedical company engaged in the optimization of human implantable tissues for complex cardiac and vascular reconstruction. In addition to tissue preservation, the company researches the development of implantable biological devices, surgical adhesives, hemostatic agents and biomaterials for use in cardiac, vascular and general surgery.
Ticker: |
CRY |
ISIN: |
US2289031005 |
Address: |
1655 Roberts Boulevard N.W., USA, Kennesaw GA, 30144 |
Website: |
CryoLife, Inc. |
Phone Number: |
770-4193355 |
|
Basic corporate social responsibility ratingsData sources for this companyRatings history Subcategory CSR ratings
| | Governance | Community |
|---|
| Board | Leadership Ethics | Transparency & Reporting | Community Dev & Philanthropy | Product | Human Rights & Supply Chain |
|---|
| CryoLife, Inc. | | | | | | |
| Biotechnology | | | | | | |
| CSRHub average | 52 | 52 | 48 | 47 | 45 | 51 |
| USA | | | | | | |
| | Employees | Environment |
|---|
| Compensation & Benefits | Diversity & Labor Rights | Training, Health & Safety | Energy & Climate Change | Policy & Reporting | Resource Management |
|---|
| CryoLife, Inc. | | | | | | |
| Biotechnology | | | | | | |
| CSRHub Average | 43 | 47 | 47 | 44 | 46 | 46 |
| USA | | | | | | |
Special issues that affect this company
Name variants
|
|
